Novome and Genentech enter into a strategic collaboration to develop targets against IBD

Date：2021-11-10

Nov 10, 2021 — Collaboration will leverage Novome’s GEMMs platform for colonizing the human gut with therapeutically engineered bacteria

CommBio Therapeutics Co., Ltd 沪ICP备2021004953号-1